Cures
Business Services · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1225 Discovery Pkwy Unit 255, Wauwatosa,...Phone Number
(262) 391-1205Website
www.bridgetocures.comRevenue
<$5 MillionIndustry
About Cures
Bridge to Cures, Inc. is dedicated to transforming healthcare innovations into products that meet unmet medical needs, emphasizing both social impact and financial return. The organization supports early-stage academic entrepreneurs by providing resources, mentoring, and access to venture capitalists, facilitating the transition from discovery to startup. Located in the Milwaukee Innovation Campus, it collaborates with the Wisconsin Economic Development Corporation and local research institutions to leverage significant healthcare research funding. Their mission is to pioneer healthcare social entrepreneurship, ensuring that medicine serves the people rather than profits.Explore more
Cures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cures
Compare insights from companies similar to Cures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cures Tech Stack
A closer look at the technologies used by Cures
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cures
Sign Up For FreeTo access detailed company insights
Bridge to Cures, Inc. is dedicated to transforming healthcare innovations into products that meet unmet medical needs, emphasizing both social impact and financial return. The organization supports early-stage academic entrepreneurs by providing resources, mentoring, and access to venture capitalists, facilitating the transition from discovery to s... Read More
